Correlation Between Alkermes Plc and Assertio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alkermes Plc and Assertio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkermes Plc and Assertio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkermes Plc and Assertio Therapeutics, you can compare the effects of market volatilities on Alkermes Plc and Assertio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkermes Plc with a short position of Assertio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkermes Plc and Assertio Therapeutics.
Diversification Opportunities for Alkermes Plc and Assertio Therapeutics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alkermes and Assertio is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Alkermes Plc and Assertio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assertio Therapeutics and Alkermes Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkermes Plc are associated (or correlated) with Assertio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assertio Therapeutics has no effect on the direction of Alkermes Plc i.e., Alkermes Plc and Assertio Therapeutics go up and down completely randomly.
Pair Corralation between Alkermes Plc and Assertio Therapeutics
Given the investment horizon of 90 days Alkermes Plc is expected to generate 0.4 times more return on investment than Assertio Therapeutics. However, Alkermes Plc is 2.51 times less risky than Assertio Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Assertio Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 2,653 in Alkermes Plc on August 28, 2024 and sell it today you would earn a total of 283.00 from holding Alkermes Plc or generate 10.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alkermes Plc vs. Assertio Therapeutics
Performance |
| Timeline |
| Alkermes Plc |
| Assertio Therapeutics |
Alkermes Plc and Assertio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alkermes Plc and Assertio Therapeutics
The main advantage of trading using opposite Alkermes Plc and Assertio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkermes Plc position performs unexpectedly, Assertio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assertio Therapeutics will offset losses from the drop in Assertio Therapeutics' long position.| Alkermes Plc vs. Intracellular Th | Alkermes Plc vs. Ironwood Pharmaceuticals | Alkermes Plc vs. Pacira BioSciences, | Alkermes Plc vs. ANI Pharmaceuticals |
| Assertio Therapeutics vs. Amneal Pharmaceuticals, Class | Assertio Therapeutics vs. Lifecore Biomedical | Assertio Therapeutics vs. Ironwood Pharmaceuticals | Assertio Therapeutics vs. Neurocrine Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |